Guide-linked quiz · Medium Level
AI in Oncology Treatment Planning Quiz
Tests oncology decision support, Watson concordance versus outcomes, tumor-board review, and the clinician’s independent evaluation of recommendations.
Question 1 of 8
What does an oncology decision-support system contribute to treatment planning?
Preview every question8 questions
Answers and explanations appear as you take the quiz.
- What does an oncology decision-support system contribute to treatment planning?
- It organizes possible options for clinicians to review
- It proves which regimen gives each patient the best survival
- It prescribes the highest-ranked regimen automatically
- It replaces tumor-board review with a model score
- What did the cited Watson for Oncology breast-cancer study measure?
- A randomized difference in survival between AI and usual care
- Diagnostic accuracy across all cancer types and hospitals
- The number of patients cured by use of the system
- Agreement with a tumor board under its stated concordance definition
- Why does a concordance percentage not prove a treatment system improves outcomes?
- The score proves the system caused better outcomes
- Agreement is a process measure, not evidence of patient benefit
- Concordance measures patient survival directly
- A match with one board guarantees the best choice for everyone
- Which patients were less likely to have concordant recommendations in the cited Watson breast-cancer study?
- Patients with receptor status recorded in the chart
- Patients treated at a hospital with a tumor board
- Patients with stage I or IV disease and older patients
- Patients whose case included prior treatment
- What should a tumor board do with an AI-suggested regimen?
- Compare it with the record, current evidence and local availability
- Adopt the first-ranked option without discussing alternatives
- Ignore patient preferences if guidelines are cited
- Use the same plan for every patient with that cancer type
- What does FDA guidance emphasize for clinician-facing decision support?
- The software should hide its inputs to avoid bias
- Only the vendor needs to understand how the options were ranked
- A fast answer should replace a time-consuming tumor board
- Clinicians should be able to review the basis for a recommendation
- Why can an option suggested in one hospital be unsuitable in another?
- Every hospital follows the same formulary
- Drug availability and treatment practices can differ
- Clinical guidelines never change
- A model automatically knows every local constraint
- What remains necessary after an AI system lists treatment choices?
- The system issues a prescription without clinician review
- The software vendor approves the final plan
- A qualified care team and patient discuss evidence, risks and goals
- The patient skips discussion of side effects
Keep testing yourself
More quizzes picked for your level.